ADVM: Adverum Biotechnologies, Inc. Stock

by  •  • Comments Off on ADVM: Adverum Biotechnologies, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 52.65
Enterprise Value ($M) 3.48
Book Value ($M) 26.42
Book Value / Share 1.26
Price / Book 1.99
NCAV ($M) -21.76
NCAV / Share -1.04
Price / NCAV -2.42

Profitability (mra)
Return on Invested Capital (ROIC) -1.26
Return on Assets (ROA) -0.56
Return on Equity (ROE) -0.83

Liquidity (mrq)
Quick Ratio 3.57
Current Ratio 3.57

Balance Sheet (mrq) ($M)
Current Assets 89.47
Assets 137.65
Liabilities 111.23
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.00
Operating Income -139.16
Net Income -130.93
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -92.46
Cash from Investing -41.89
Cash from Financing 120.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Venrock Healthcare Capital Partners III, L.P. 0.00 -100.00
12-17 13G Rush Ryan Bradford 5.10
11-14 13G/A Vivo Opportunity Fund Holdings, L.P. 1.10 -98.54
11-14 13G/A Commodore Capital Lp 0.00 -100.00
11-14 13G/A Logos Global Management LP 2.00 -97.22
11-12 13G/A Fmr Llc 1.13 -96.17
11-08 13G BlackRock, Inc. 7.20 0.00
11-06 13G/A Morgan Stanley 0.40 -98.47
10-31 13G Franklin Resources Inc 8.50
10-30 13G Stern Augustus 5.37
10-23 13G Principia Wealth Advisory, LLC 5.07
07-22 13G/A BML Investment Partners, L.P. 10.60 93.37
2024-05-14 13D/A Versant Ventures IV, LLC 2.40 -90.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-04-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K _______________________________________________________________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For
2024-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-03 64,823 322,731 20.09
2025-06-02 42,280 169,585 24.93
2025-05-30 60,131 161,212 37.30
2025-05-29 24,460 70,682 34.61

(click for more detail)

Similar Companies
ACXP – Acurx Pharmaceuticals, Inc. ADIL – Adial Pharmaceuticals, Inc.
ADTX – Aditxt, Inc. AGEN – Agenus Inc.
AIMD – Ainos, Inc.


Financial data and stock pages provided by
Fintel.io